A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the leading cause of coronavirus disease-2019 (COVID-19), is an emerging global health crisis. Lung cancer patients are at a higher risk of COVID-19 infection. With the increasing number of non-small-cell lung cancer (NSCLC) patients with COVID-19, there is an urgent need of efficacious drugs for the treatment of COVID-19/NSCLC.Methods: Based on a comprehensive bioinformatic and systemic biological analysis, this study investigateddoi:10.3389/fphar.2022.857730 pmid:35721149 pmcid:PMC9201692 fatcat:s4w6jrp3gzc63arnh6cxkunwcy